Since the gene expression signatures of claudin-low tumors and claudin-low cell lines show a significant similarity to the signature of CSCs [20, 22], we examined the relationship between ADAM12 mRNA expression and the CSC signature scores in a panel of 51 breast cancer cell lines from Neve at al. [26]. This evidence concerns the gene ADAM12 and breast carcinoma.